AstraZeneca
AZN
AZN
751 hedge funds and large institutions have $20.4B invested in AstraZeneca in 2021 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 264 increasing their positions, 268 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
751
Holders Change
-31
Holders Change %
-3.96%
% of All Funds
13.22%
Holding in Top 10
14
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-22.22%
% of All Funds
0.25%
New
77
Increased
264
Reduced
268
Closed
100
Calls
$548M
Puts
$409M
Net Calls
+$138M
Net Calls Change
+$107M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.96B |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$205M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$153M |
| 4 |
Citigroup
New York
|
+$116M |
| 5 |
BlackRock
New York
|
+$86.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$661M |
| 2 |
Jennison Associates
New York
|
-$348M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$307M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$229M |
| 5 |
D.E. Shaw & Co
New York
|
-$214M |
